The FTSE 100 ended the week with a 1.5% increase. Leading the gains was NatWest, which saw its shares climb 7.09% following the confirmation of its new chief executive. Close
N4 Pharma PLC (AIM:N4P) in-vitro siRNA update
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments, gene therapy and vaccines, is pleased to provide a further encouraging update
RNS Hotlist with Zak Mir: GENF, BOOM, YCA, ROCK, VRS, AVCT, ANGS, CYK, PXEN & N4P
Genflow Bioscience (GENF) yesterday afternoon announced two research grants totally €2.9m to develop gene therapies that increase human life spans with better health.
N4 Pharma PLC (AIM:N4P) Patent Grant
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments, gene therapy and vaccines, is pleased to announce that the University of Queensland has informed
RNS Hotlist with Zak Mir: THG, LIFS, BLU, NTOG, COPL, BIRD, CMRS, CABP, KIBO, BHL, EQLS, CODE, IQE, HEMO, N4P & MCB
Panmure Gordon and Liberum today announced an all-share merger to create the UK’s largest independent Investment Bank.
N4 Pharma PLC (AIM:N4P) Nanogenics Update
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments, gene therapy and vaccines, is pleased to provide an update on its
N4 Pharma PLC (AIM:N4P) AAV Viral Vector Update
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments, gene therapy and vaccines, is pleased to provide a further successful update
Trader’s Café With Zak Mir: The Week In Small Caps, Sunday 7th January 2024
It is difficult to look forward to 2024 without some degree of trepidation. After all, just because 2023 was exceptionally bad for most small caps, we are not necessarily due
Traders Cafe with Zak Mir: Bulletin Board Heroes, Monday 18th December 2023
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Gold, Ananda, Chill,
N4 Pharma PLC (AIM:N4P) Oral Delivery Update
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide a positive update on its ongoing
N4 Pharma PLC (AIM:N4P) Nuvec® R&D and Strategy Update
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide an encouraging update on its ongoing in
RNS Hotlist with Zak Mir: N4P, SNX, CIZ, BHL, AVCT, ME1, TM1, AST, COBR, PXC, RBD, HUM, DKL, SVML, ALL & GENF
N4 Pharma (N4P), the specialist pharmaceutical company developing Nuvec®, announced the acquisition of a controlling interest, through a subscription for new ordinary shares, in Nanogenics Limited, a company with a complementary